Tuesday, May 17, 2022
Home Medical Cannabis News Cannabis & CBD Product News

Cannabis & CBD Product News

Medical Cannabis Network brings you the latest medical cannabis & CBD product news from across the medicinal cannabis & CBD sector.

Innovation in European cannabis

Symtomax: innovation in European cannabis

Portugal-based cannabis producer Symtomax deploys industry experience and genetic expertise to deliver high-quality, market-leading products. Symtomax has been granted approval by INFARMED, the Portuguese regulatory...
UK prescription cannabis recalled for containing toxic mould

UK prescription cannabis recalled that ‘may be contaminated with mould’

UK prescription cannabis supplier NOIDECS has recalled two batches of product and has advised patients not to use their prescription medicine after reports of...
Exploring the emerging UK CBD industry

Exploring the emerging UK CBD industry

In this article, Rick Brar, CEO of Brains Bioceutical, explores the emerging UK CBD industry. The last two years have seen the UK CBD market...
GCI Summit: exploring cannabis and psychedelics

GCI Summit: exploring cannabis and psychedelics

This week, the GCI Summit gives global leaders the opportunity to network with the best minds in cannabis and psychedelics. Taking place from 8 to...
Natural versus synthetic CBD

Natural versus synthetic CBD

Richard O’Halloran, CEO of Biosportart, discusses natural versus synthetic cannabidiol (CBD) compounds for use in products and what this means for the CBD industry. CBD...
mescaline

XPhyto: Is mescaline the next big mood-modifying medicine?

Mescaline has the potential to be the next frontier in the psychedelics renaissance and represents an unprecedented opportunity to innovate a notable advancement in...
Greenheart CBD: the first CBD company to introduce DeFi token

Greenheart CBD: the first company to introduce a CBD DeFi token

Greenheart offers premium seed-to-shelf CBD and an innovative decentralised finance token. Greenheart CBD is an Irish-owned company with a vision to bring the finest Irish-made...
Cannalean cannabis edibles for reducing cholesterol

Cannalean cannabis edibles for reducing cholesterol

Cannalean’s unique CBD formulation could help to treat dyslipidaemia, without the side effects of statins. My 52-year-old husband is usually very healthy. He exercises daily,...
Medical cannabis ‘made in Denmark’

Medical cannabis ‘made in Denmark’

How Aurora Europe is ensuring reliable access to high-quality medical cannabis for Europe and beyond. There is growing recognition in Europe and across the world...
Medical cannabis for endometriosis pain management

Medical cannabis for endometriosis pain management

During Endometriosis Awareness Month, Sapphire Medical Clinics discusses how medical cannabis can help manage the chronic pain associated with the condition. Endometriosis is often associated...
The future of CBD wellness products

The future of CBD wellness products

The future is looking promising for businesses hoping to tap into the growing CBD and wellness space. The global market for cannabidiol (CBD), valued at...
Australian biotech company leads the way medical cannabis

Australian biotech company leads the way medical cannabis

CannaPacific is building a solid foundation to become a major player in the global medical cannabis sector. A little-known Australian biotech company, CannaPacific, is building...
Khiron extends medical cannabis expertise from Latin America to Europe

Khiron extends medical cannabis expertise from Latin America to Europe

Khiron extends expertise towards the growing EU medical cannabis market. Khiron Life Sciences is a patient-focused, global health and wellness company capitalising on the fast-growing...
Cannabis investment, regulation, and opportunity in Latin America

Cannabis investment, regulation, and opportunity in Latin America

How a Canadian company is meeting the demand for pharmaceutical cannabis products in Latin America. The primary goal of Canadian supplier VerdeMed is to deliver...
Project Twenty21 receives new medical cannabis range

Project Twenty21 receives new medical cannabis range

Project Twenty21 and LYPHE Group have created a partnership for a new range of medical cannabis products for the registry. The partnership will see LYPHE...
New UK medical cannabis products cheaper and safer than black market

New UK medical cannabis products cheaper and safer than black market

Sapphire Medical Clinics are first to offer access to a new range of UK manufactured medical cannabis products which are now cheaper and safer...
Medical cannabis: science and risk-based methodology

Medical cannabis: science and risk-based methodology

Independent consultancy NNE and venture advisory firm Volvér showcase the significance of science and risk in devising a manufacturing facility. How can cannabis producers bring...
LeafCann secures cannabis import licence from Australian Government

LeafCann secures cannabis import licence from Australian Government

Privately-owned medicinal cannabis company LeafCann has secured a Medicinal Cannabis import licence from the Australian Government. The licence, which will enable LeafCann to supply Australian...
Cloud 9 Switzerland Group: nutraceuticals and pharmaceuticals

Cloud 9 Switzerland Group: nutraceuticals and pharmaceuticals

Life sciences company Cloud 9 Switzerland prioritises patient wellbeing, product quality and innovation in clinical practice. Cloud 9 Switzerland is a life sciences company offering...
The Valens Company explore the importance of edibles testing

The Valens Company explore the importance of edibles testing

Jeff Fallows, President of The Valens Company, explores the need for product standardisation in a uniquely challenging market. By 2022, the global worth of the...

Medical Cannabis eBooks

Medical Cannabis Partners

Pin It on Pinterest